REFERENCES
- Eibl H, Unger C. Hexadecylphosphocholine: a new and selective antitumor drug. Cancer Treat Rev. 1990; 17: 233–242, [PUBMED], [INFOTRIEVE]
- Hilgard P, Engel J. Clinical aspects of miltefosine and its topical formulation Miltex®. Drugs Today. 1994; 30(Suppl. B)3–81
- Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, Mansi J. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol. 2001; 21: 4150–4159
- Kuhlencord A, Maniera T, Eibl H, Unger C. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob Agents Chemother. 1992; 36: 1630–1634, [PUBMED], [INFOTRIEVE], [CSA]
- Sundar S, Jha T K, Thakur C P, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med. 2002; 347: 1739–1746, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kötting J, Berger M R, Unger C, Eibl H. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations. Cancer Chemother Pharmacol. 1992; 30: 105–112, [CROSSREF]
- Sobottka S B, Berger M R, Eibl H. Structure-activity relationships of four anticancer alkylphosphocholine derivatives in vitro and in vivo. Int J Cancer. 1993; 53: 418–425, [PUBMED], [INFOTRIEVE]
- Eibl K H, Banas B, Schoenfeld C L, Neubauer A S, Priglinger S, Kampik A, Welge-Luessen U. Alkylphosphocholines inhibit proliferation of human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2003; 44: 3556–3561, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hiscott P S, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol. 1984; 68: 708–715, [PUBMED], [INFOTRIEVE]
- Hiscott P, Sheridan C, Magee R M, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999; 18: 167–190, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Asaria R HY, Kon C H, Bunce C, Charteris D G, Wong D, Khaw P T, Aylward G W. Adjuvant 5-fluouracil and heparin prevents proliferative vitreoretinopathy. Ophthalmology. 2001; 108: 1179–1183, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zheng B, Oishi K, Shoji M, Eibl H, Berdel W E, Hajdu J, Vogler W R, Kuo J F. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res. 1990; 50: 3025–3031, [PUBMED], [INFOTRIEVE]
- Shoji M, Raynor R L, Fleer E AM, Eibl H, Vogler W R, Kuo J F. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells. Lipids 1991; 26: 145–149, [PUBMED], [INFOTRIEVE]
- Überall F, Oberhuber H, Maly K, Zaknun J, Demuth L, Grunicke H H. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res. 1991; 51: 807–812
- Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992; 258: 607–614, [PUBMED], [INFOTRIEVE]
- Erdlenbruch B, Jendrossek V, Gerriets A, Vetterlein F, Eibl H, Lakomek M. Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration. Cancer Chemother Pharmacol. 1999; 44: 484–490, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cannon J P, Fiscella R, Pattharachayakul S, Garey K W, De Alba F, Piscitelli S, Edward D P, Danziger L H. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci. 2003; 44: 2112–2117, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maia M, Margalit E, Lakhanpal R, Tso M O, Grebe R, Torres G, Eong K G, Farah M E, Fujii G Y, Weiland J, et al. Effects of intravitreal indocyanine green injection in rabbits. Retina. 2004; 24: 69–79, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rowley S A, Vijayasekaran S, Yu P K, McAllister I L, Yu D Y. Retinal toxicity of intravitreal tenecteplase in the rabbit. Br J Ophthalmol. 2004; 88: 573–578, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sun Q, Ooi V E, Chan S O. N-methyl-D-aspartate-induced excitotoxicity in adult rat retina is antagonized by single systemic injection of MK-801. Exp Brain Res. 2001; 138: 37–45, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Macky T A, Oelkers C, Rix U, Heredia M L, Kunzel E, Wimberly M, Rohrer B, Crosson C E, Rohr J. Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of y novel mitomycin C-triamcinolone acetonide conjugate. J Med Chem. 2002; 45: 1122–1127, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Enaida H, Sakamoto T, Hisatomi T, Goto Y, Ishibashi T. Morphological and functional damage of the retina caused by intravitreous indocyanine in rat eyes. Graefes Arch Clin Exp Ophthalmol. 2002; 240: 209–213, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chidlow G, Osborne N N. Rat retinal ganglion cell loss caused by kainate, NMDA and ischemia correlated with a reduction in mRNA and protein of Thy-1 and neurofilament light. Brain Res. 2003; 963: 298–306, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rejdak R, Zarnowski T, Turski W A, Kocki T, Zagorski Z, Zrenner E, Schuettauf F. Alterations of kynurenic acid content in the retina in response to retinal ganglion cell damage. Vision Res. 2003; 43: 497–503, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dalke C, Löster J, Fuchs H, Gailus-Durner V, Soewarto D, Favor J, Neuhäuser-Klaus A, Pretsch W, Gekeler F, Shinoda K, et al. Electroretinography as a screening method for mutations causing retinal dysfunction in mice. Invest Ophthalmol Vis Sci. 2004; 45: 601–609, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schuettauf F, Naskar R, Vorwerk C K, Zurakowski D, Dreyer E B. Ganglion cell loss after optic nerve crush mediated through AMPA-Kainate and NMDA receptors. Invest Ophthalmol Vis Sci. 2000; 41: 4313–4316, [PUBMED], [INFOTRIEVE], [CSA]
- Seme M T, Summerfelt P, Neitz J, Eells J T, Henry M M. Differential recovery of retinal function after mitochondrial inhibition by methanol intoxication. Invest Ophthalmol Vis Sci. 2001; 42: 834–841, [PUBMED], [INFOTRIEVE], [CSA]
- Goto W, Ota T, Morikawa N, Otori Y, Hara H, Kawazu K, Miyawaki N, Tano Y. Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina. Brain Res. 2002; 958: 10–19, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yoneda S, Tanaka E, Goto W, Ota T, Hara H. Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Res. 2003; 967: 257–266, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Goto Y, Taniwaki T, Shigematsu J, Tobimatsu S. The long-term effects of antiepileptic drugs on the visual system in rats: electrophysiological and histopathological studies. Clinic Neurophysiol. 2003; 114: 1395–1402, [CROSSREF], [CSA]
- Theischen M, Bornfeld N, Becher R, Keller U, Wessing A. Hexadecylphosphocholine may produce reversible functional defects of the retinal pigment epithelium. Ger J Ophthalmol. 1993; 2: 113–115, [PUBMED], [INFOTRIEVE]